The Global Nasal Drug Delivery Market Overview and Analysis by Drug Type
(Anesthetics, Antibiotics), Dosage Form (Drops, Sprays), Basis of System (Unit
Dose, Multi-Dose), Delivery Technologies (Spray, Nebulizers), Therapeutic
Applications (Rhinitis, Asthma) End User (Home Care Settings) and Region (the
Americas, Europe, Asia-Pacific, and the Middle East & Africa)—Forecast till
2030
Due to growing preference noninvasive
medical treatment for various ailments, the intra-nasal route of drug
administration is gaining popularity. Not only it reduces pain and infections; it allows the patient
the patient to self-administer drugs independently. Recent research has also pointed out its applications related to drug
delivery to the brain. Nasal drugs market also have lesser side effects
compared to other drugs. Due to nasal drugs, the concept of bioavailability is
becoming popular, which is defined as the
proportion of a drug that enters the human body via systemic circulation as
compared to the dosage. The popularity
of inhalers is driving the market.
Market Research Future (MRFR) has
published a research report that visualizes huge increase for the Middle East
& Africa (MEA) nasal drug delivery market with 7.50% CAGR (Compound Annual
Growth Rate) between 2022 and 2030. In terms of cash, the market is expected to
rise to US $ 1.59 bn. Some more factors
that drive this market include ease of
administration, growing efficacy of the route due to the development of drugs,
that is absorbed easily from the nasal route and the development of advanced
products. Metered dose pressurized containers are capable of delivering
the precise dose. This report evaluates
the market structure and features expert opinions that help readers to
understand the market scenario with future growth potential. It also analyzes
the competitive developments of this market. The factors that can hinder the
market growth include irritation of the nasal route, low awareness and
concurrent low popularity of the route, and a low
dose of the drug. Due to low awareness and low popularity, few companies nasal
drugs delivery. This makes the market for
nasal drug delivery has oligopolistic with a few
dominant players. Oligopoly gives more power to
sellers.
The MEA nasal drug delivery market size has been segmented on the basis of
delivery technologies, dosage form, system, therapeutic applications, and
lastly region. On the basis of delivery technologies, this market has been
segmented as nebulizers, spray, and other. A
nebulizer is a device that is used to administer medication in the form
of a mist inhaled by the patient into
his/her lungs. Based on the dosage form,
the market has been segmented into drops, gels, ointments, powder, and sprays.
The system-based segmentation of the
market covers unit dose, metered dose, and multi-dose. Unit dose is defined as
the amount of a medication administered to a patient in a single dose. A
metered dose is delivered as a specific amount of medication to the lungs via
an inhaler. It is delivered in the form of a short burst of aerosolized
medicine that is usually self-administered by the patient via inhalation. Delivered via vial of liquid medication,
multi-dose is intended for injection or infusion that contains more than one
dose of medication. On the basis of therapeutic
applications, the market has been segmented into congestion, rhinitis,
vaccinations, and others.
The regional segmentation of the global
nasal drug delivery market segments the market into regional markets known as
the Middle East and Africa. Overall, the biggest market in the United Arab Emirates
(UAE), followed by Egypt. UAE is the biggest market in the Middle East whereas Egypt is the biggest market in Africa. In the remaining
Middle East region, the market is limited due to lack of technological
advancement, lack of education, political instability, and low investment on healthcare by the government due to healthcare not considered a priority. In Africa,
the market is growing rapidly due to huge unmet medical needs and the growing popularity of the nasal route.
Key Players
The key players MEA nasal drug delivery
market include AptarGroup Inc. {United States of America (USA)}, Becton Dickson
& Company (USA), GlaxoSmithKline PLC {United Kingdom (UK)}, Johnson &
Johnson Services Inc. (USA), Merck & Co. Inc. (USA), Novartis AG
(Switzerland), Pfizer Inc. (USA), and Sanofi-Aventis (France).
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
0 Comments